¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"forbidden clone hypothesis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aberrant clone
    ÀÌ»óŬ·Ð
  • clone
    Ŭ·Ð, Çѹ«¸®
  • clone purification
    Ŭ·ÐÁ¤Á¦
  • clonogenic clone
    Ŭ·Ð¿ø¼ºÅ¬·Ð
  • hypothesis
    °¡¼³
  • lattice hypothesis
    °ÝÀÚ°¡¼³
  • null hypothesis
    ¿µ°¡¼³, ±Í¹«°¡¼³
  • unitarian hypothesis
    Ç×üµ¿Àϰ¡¼³
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • clone
    Ŭ·Ð, ¹«¸®
  • hypothesis
    °¡¼³
  • null hypothesis
    ±Í¹«°¡¼³, ¿µ°¡¼³
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aberrant clone
    ÀÌ»óŬ·Ð
  • clone
    Ŭ·Ð, ¹«¸®
  • clone purification
    Ŭ·ÐÁ¤Á¦
  • clonogenic clone
    Ŭ·Ð¿ø¼ºÅ¬·Ð
  • blending hypothesis
    À¶ÇÕÀ¯Àü¼³
  • central plasticity hypothesis
    ÁßÃßÀ¯¿¬¼º°¡¼³
  • countercurrent hypothesis
    ¿ª·ù°¡¼³
  • drift hypothesis
    À̵¿°¡¼³
  • dual recognition hypothesis
    Ç׿øÀÌÁßÀÎÁö°¡¼³
  • estrogen window hypothesis
    ¿¡½ºÆ®·Î°Õâ°¡¼³
  • expectation hypothesis
    ¿¹Ãø°¡¼³
  • hypothesis
    °¡¼³
  • hypoxia-selectivity hypothesis
    Àú»ê¼ÒÁõ¼±Åõµ°¡¼³
  • lattice hypothesis
    °ÝÀÚ°¡¼³
  • lipid hypothesis
    ÁöÁú°¡¼³
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aberrant clone
    ÀÌ»óŬ·Ð.
  • Glucostatic hypothesis, of appetite regulation
    Ç×´ç±â¼³(ù÷ÓØÐñæò), ½Ä¿åÁ¶Àý(ãÝé¯ðàï½)
  • Lyon s hypothesis
    ¶óÀ̿°¡¼³.
  • Starling s hypothesis
    ½ºÅ¸¾Ë¸µ°¡¼³.
  • hypothesis, lattice
    °ÝÀÚ¼³
  • receptor hypothesis
    ¼ö¿ëü°¡¼³
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • clone, forbidden
    ±ÝÁöŬ·Ð
  • forbidden clone
    ±ÝÁö Ŭ·Ð
  • aberrant clone
    ÀÌ»óŬ·Ð.
  • clone
    Ŭ·Ð
  • clone purification
    Ŭ·Ð¼ø¼öºÐ¸®
  • clonogenic clone
    Ŭ·Ð¿ø¼ºÅ¬·Ð
  • atherosclerosis,monoclonal hypothesis
    ´ÜÀÏŬ·Ð¼º°¡¼³(Ó¤ìé¡­Ê£àã)
  • atherosclerosis,reaction to injury hypothesis
    ¼Õ»ó¿¡ ´ëÇÑ ¹ÝÀÀ±âÀü
  • atomic hypothesis
    ¿øÀÚ°¡¼³(ê«í­Ê£æò).
  • blending hypothesis
    À¶ÇÕÀ¯Àü¼³(¡­ë¶îîæò).
  • countercurrent hypothesis
    ¿ª·ù°¡¼³ (¡­Ê£æò).
  • cyclol hypothesis
    »çÀÌŬ·Ñ ´ÜÀ§°¡¼³(¡­Ó¤êÈÊ£æò).
  • dopamine hypothesis
    µµÆÄ¹Î °¡¼³
  • drift hypothesis
    À̵¿°¡¼³
  • dual recognition hypothesis
    Ç׿øÀÌÁßÀÎÁö°¡¼³
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • forbidden clone hypothesis
    ±ÝÁö(Ð×ò­) Ŭ·Ð¼³(àã)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cDNA clone
    cDNA Ŭ·Ð
  • clone
    Ŭ·Ð
  • clone library
    Ŭ·Ð ¶óÀ̺귯¸®
  • DNA clone
    DNA Ŭ·Ð
  • acetate hypothesis
    ¾Æ¼¼Æ®»ê(ß«) ¼³(àã)
  • adapter hypothesis
    ¾Æ´äÅͼ³(àã)
  • adenylate charge hypothesis
    ¾Æµ¥´Ò»ê(ß«)´ëÀü¼³(Óáï³àã)
  • adenylate control hypothesis
    ¾Æµ¥´Ò»ê(ß«)Á¶Àý¼³(ðàï½àã)
  • Akabori hypothesis
    ¾ÆÄ«º¸¸®¼³(àã)
  • autocrine hypothesis
    ÀÚ°¡ºÐºñ¼³ (í»Ê«ÝÂÝôàã)
  • Belling's hypothesis
    º§¸µ¼³(àã)
  • biochemical coupling hypothesis
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ) ¦ÁöÀ½¼³(àã)
  • biochemical deletion hypothesis
    »ýÈ­ÇÐÀû(ßæûùùÊîÜ)°á½Ç¼³(ÌÀã÷àã)
  • biogenic amine hypothesis
    »ýü(ßæô÷)¾Æ¹Î¼³(àã)
  • bookmark hypothesis
    ¼­Ç¥¼³(ßöøöàã)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypothesis
    °¡¼³
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NGFIA nerve growth factor-induced clone A
NGFIC nerve growth factor-induced clone C
H0 null hypothesis
H1 alternative hypothesis
LNH large number hypothesis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
(3)H hypothesis that
NT2/D1 N-Tera-2 clone D1
TCC T cell clone
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • forbidden clone
    ±ÝÁö Ŭ·Ð
  • B cell clone
    B ¼¼Æ÷ Ŭ·Ð
    Ŭ·ÐÀ̶õ ´ÜÀÏÀÇ ¼¼Æ÷¸¦ Á¶»óÀ¸·Î ÇÏ´Â 1±ºÀÇ ¼¼Æ÷¸¦ ¸»ÇÑ´Ù. µû¶ó¼­ B ¼¼Æ÷ Ŭ·ÐÀº ´ÜÀÏÀÇ B ¼¼Æ÷°¡ ºÐ¿­, Áõ½ÄÇÏ¿© Çü¼ºÇÑ B ¼¼Æ÷ Áý´ÜÀ» ¸»ÇÑ´Ù. ÀÌ °æ¿ì µ¿ÀÏÇÑ ¸é¿ª ±Û·ÎºÒ¸° V À¯ÀüÀÚ¸¦ ¹ßÇöÇϰí ÀÖ´Â B ¼¼Æ÷·Î »ý°¢ÇÒ ¼ö ÀÖ´Ù. Á¤»óÀÇ B¼¼Æ÷´Â ¾Æ´ÏÁö¸¸ ¼¼Æ÷À¶ÇÕ¹ýÀ¸·Î ¾ò¾îÁø B ¼¼Æ÷ À¶ÇÕÁ¾µµ ¶Ç B¼¼Æ÷ Ŭ·ÐÀ̶ó°í ºÒ¸®¿ì´Â ¼ö°¡ ÀÖ´Ù.
  • clone
    Ŭ·Ð, ºÐÁö°è, ¿µ¾ç°è
    ¹«¼º ºÐ¿­ÀÇ °á°ú »ý±ä ¼¼Æ÷±ºÀ» ¸»ÇÏ¸ç °á±¹ À¯ÀüÀûÀΠƯ¡ÀÌ µ¿ÀÏÇÑ °ÍÀÌ´Ù.
  • altered-self hypothesis
    º¯È­ÇÑ ÀÚ±â Ç׿ø °¡¼³
    T-B Çùµ¿ÀÛ¿ëÀ̳ª Killer T ¼¼Æ÷ÀÇ Ç¥Àû¼¼Æ÷ÀÇ ÀÎ½Ä ±â±¸¿¡ À־ ¸²ÇÁ±¸´Â ¹ÝÀÀÇÏ´Â »ó´ëÀÇ ±¸Á¶·Î¼­ ºñÀÚ±âÀÎ Ç׿ø°ú ÀÚ±âÀÎ MHCÀÇ ¾çÂÊÀ» ÀνÄÇϰí ÀÖ´Ù. ÀÌ °æ¿ì »ý°¢ÇÏ´Â ¹æ½Ä¿¡ µÎ °³ÀÇ ¹æ½ÄÀÌ ÀÖÀ¸¸ç ºñÀÚ±â¿Í ÀڱⰡ ÇϳªÀÇ °ÍÀ¸·Î¼­ ÇÑ Á¾·ùÀÇ ¼ö¿ëü¿¡ ÀÇÇÏ¿© ÀÎ½ÄµÈ´Ù°í »ý°¢ÇÏ´Â °ÍÀÌ º¯È­ÇÑ ÀÚ°¡ Ç׿ø °¡¼³ÀÇ »ý°¢ ¹æ½ÄÀÌ´Ù.
  • convergence-projection hypothesis
    ÆøÁÖ Åõ»ç °¡¼³
  • dual recognition hypothesis
    2Áß Àνļ³
    ¸é¿ª ¼¼Æ÷ »çÀÌÀÇ »óÈ£ ÀÛ¿ë¿¡ À־ÀÇ T ¼¼Æ÷ÀÇ ÀÎ½Ä ±â±¸¿¡ °üÇÑ °¡¼³ÀÇ Çϳª. T ¼¼Æ÷¿¡´Â ÀÚ±âÀÇ MHC ºÐÀÚ¸¦ ÀνÄÇϱâ À§ÇÑ ¼ö¿ëü¿Í ´Ù¸¥ °ÍÀ» ÀνÄÇϱâ À§ÇÑ ¼ö¿ëü°¡ °¢°¢ µ¶¸³ÇÏ¿© Á¸ÀçÇÑ´Ù°í ÇÏ´Â »ý°¢.
  • hypothesis
    °¡¼³
    ¸î °¡ÁöÀÇ Çö»óÀ» ¼³¸íÇÒ ¼ö ÀÖÀ¸¸ç Ãß·ÐÀ̳ª ½ÇÇèÀ» ±âÃÊ·Î ÇÏ¿© °¡Á¤µÈ ÃßÃø.
  • Starling's hypothesis
    ½ºÅ»¸µÀÇ °¡¼³
  • unitarian hypothesis
    Ç×ü µ¿Àϼ³
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
forbidden Prohibited; interdicted. "I knew no spells, use no forbidden arts." (Milton) Forbidden fruit. Any coveted unlawful pleasure, so called with reference to the forbidden fruit of the Garden of Eden.
<botany> A small variety of shaddock (Citrus decumana). The name is given in different places to several varieties of Citrus fruits.
(04 Apr 1998)
recombinant clone <molecular biology> Clones containing recombinant DNA molecules.
See: recombinant DNA technologies.
(14 Oct 1997)
cDNA clone A duplex DNA, representing an mRNA, carried in a cloning vector.
(05 Mar 2000)
clone <cell biology> A propagating population of organisms, either single cell or multicellular, derived from a single progenitor cell. Such organisms should be genetically identical, though mutation events may abrogate this.
(18 Nov 1997)
clone bank <molecular biology> A collection of DNA molecules, derived from restriction fragments that have been cloned in vectors, that includes all or part of the genetic material of an organism.
(18 Nov 1997)
clone cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence.
(12 Dec 1998)
adaptor hypothesis A hypothesis, proposed by F.H.C. Crick, that an adaptor molecule must be present between the information-containing DNA and the protein being synthesised.
(05 Mar 2000)
altered self hypothesis The hypothesis that the T-cell receptor in MHC mediated phenomena recognises a syngeneic MHC Class I or Class II molecule after modification by a virus or certain chemicals.
See: MHC restriction.
(18 Nov 1997)
alternative hypothesis In Neyman-Pearson testing of a hypothesis, the hypothesis or family of hypotheses about the numerical value of a parameter if and only if the null hypothesis is rejected as untenable.
(05 Mar 2000)
autocrine hypothesis That tumour cells containing viral oncogenes may have encoded a growth factor, normally produced by other cell types, and thereby produce the factor autonomously, leading to uncontrolled proliferation.
(05 Mar 2000)
Avogadro's hypothesis <physics> The hypothesis that equal volumes of two different gases at the same temperature and pressure contain the same number of molecules.
(02 Jan 1998)
Bayesian hypothesis An array of surmised values of a parameter to be severally explored in the light of a current set of data, with logical symmetry being preserved among all. The merits of each hypothesis entertained are based on quantity, the prior probability. The probability of the data conditional on the hypothesis is computed as the conditional probability for each; the product of the two for each hypothesis is the joint probability, and the ratio of each joint probability to the sum of all the joint probabilities is the posterior probability for that hypothesis. Unlike the Neyman-Pearson test of hypotheses, the answer is a statement about the hypothesis, not about the sample conditional on the hypothesis. No hypothesis is preferred or prevails by default. The procedure may be applied recursively any number of times, as the data becomes available.
(05 Mar 2000)
Makeham's hypothesis A development of Gompertz' hypothesis as to the force of mortality following some mathematical law. Makeham assumed that death was the consequence of two generally coexisting causes: 1) chance; 2) a deterioration or increased inability to withstand destruction. The first of these is constant, the second is an increasing geometrical progression.
(05 Mar 2000)
gate-control hypothesis A theory to explain the mechanism of pain; small fibre afferent stimuli, particularly pain, entering the substantia gelatinosa can be modulated by large fibre afferent stimuli and descending spinal pathways so that their transmission to ascending spinal pathways is blocked (gated).
Synonym: gate-control hypothesis.
(05 Mar 2000)
Gompertz' hypothesis A theory that the force of mortality increases in geometrical progression, being based on the assumption that the average exhaustion of a person's power to avoid death is such that at the end of equal infinitely small intervals of time he loses equal proportions of the power to oppose destruction which he had at the commencement of each of these intervals.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • clone
    ¿µ¾ç°è
  • clone
    ¿µ¾ç°è;Ŭ·Ð(¿µ¾ç »ý½Ä¿¡ ÀÇÇÏ¿© ¸ðü·Î ºÎÅÍ ºÐ¸® Áõ½ÄÇÑ ½Ä¹°±º);Ŭ·Ð(±× °³Ã¼ ¶Ç´Â ¼¼Æ÷);(º¹»çÇÑ °Íó·³)¶È°°Àº »ç¶÷(°Í);ÄÚÇÇ(Àΰ£);(¾Æ¹« »ý°¢ ¾øÀÌ)±â°èÀûÀ¸·Î ÇൿÇÏ´Â »ç¶÷;(´Ü¤·¤© °³Ã¼ µî¿¡¼­)Ŭ·ÐÀ» ¹Îµé´Ù
  • hypothesis
    °¡¼³
  • efficient market hypothesis
    (Áõ±Ç)È¿À²Àû ½ÃÀå °¡¼³(»õ·Î¿î Á¤º¸ÀÇ ÁÖ°¡¿¡ÀÇ ¹ÝÀÀÀº µ¿½ÃÀûÀ̶õ °¡¼³)
  • hypothesis
    °¡¼³;°¡Á¤
  • nebular hypothesis(theory)
    (õ)(žç°èÀÇ)¼º¿î¼³
  • Forbidden Ciy
    ±Ý´ÜÀÇ µµ½Ã(ºÏ°æÀÇ Àڱݼº)
  • forbidden
    forbidÀǰú°Å;±ÝÁöµÈ;±Ý´ÜÀÇ
  • forbidden degree
    ±ÝÈ¥ Ã̼ö 
  • forbidden fruit
    ±Ý´ÜÀÇ ¿­¸Å(¾Æ´ã°ú À̺갡 µû ¸Ô°í ¿¡µ§ µ¿»ê¿¡¼­ ÂѰܳ²);ºÒÀÇ Äè¶ô
  • forbidden ground
    ±Ý´ÜÀÇ Àå¼Ò;ÅäÀÇÇØ¼­´Â ¾ÈµÇ´Â ¹®Á¦;¸»Çؼ­´Â ¾ÈµÇ´Â ÀÏ
  • forbidden line
    (½ºÆåÆ®·³ÀÇ) ±ÝÁ¦¼±
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á